11 hours Vertex Down 13% in 6 Months: Buy, Sell or Hold the Stock? Zacks
Those who already own the stock may retain it for some time to see if VRTX’s CF sales continue to rise and how the Casgevy launch progresses.
Pharmaceuticals · Vertex (VRTX)
X